Metronidazole therapy for treating dientamoebiasis in children is not associated with better clinical outcomes: a randomized, double-blinded and placebo-controlled clinical trial.

Röser, Dennis; Simonsen, Jacob; Stensvold, Christen Rune; Olsen, Katharina E P; Bytzer, Peter; Nielsen, Henrik V; Mølbak, Kåre

Röser, Dennis; Simonsen, Jacob; Stensvold, Christen Rune; Olsen, Katharina E P; Bytzer, Peter; Nielsen, Henrik V; Mølbak, Kåre.

Affiliation

Röser D; Department of Microbiology and Infection Control.
Simonsen J; Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen, Denmark.
Stensvold CR; Department of Microbiology and Infection Control.
Olsen KE; Department of Microbiology and Infection Control.
Bytzer P; Faculty of Health Sciences, Department of Medicine, Copenhagen University, Køge University Hospital, Denmark.
Nielsen HV; Department of Microbiology and Infection Control.
Mølbak K; Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen, Denmark.

Clin Infect Dis ; 58(12): 1692-9, 2014 Jun.

Article de En | MEDLINE | ID: mdl-24647023

Sujet(s)
Mots clés

Dientamoeba fragilis; RCT; antimicrobial; pathogenicity; pediatric

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infection à Dientamoeba / Métronidazole / Anti-infectieux Type d'étude: Clinical_trials / Risk_factors_studies Limites: Child / Child, preschool / Female / Humans / Male Pays/Région comme sujet: Europa Langue: En Journal: Clin Infect Dis Sujet du journal: DOENCAS TRANSMISSIVEIS Année: 2014 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google